AR045000A1 - Gen y proteina de eimeria , y su uso - Google Patents
Gen y proteina de eimeria , y su usoInfo
- Publication number
- AR045000A1 AR045000A1 ARP040102341A ARP040102341A AR045000A1 AR 045000 A1 AR045000 A1 AR 045000A1 AR P040102341 A ARP040102341 A AR P040102341A AR P040102341 A ARP040102341 A AR P040102341A AR 045000 A1 AR045000 A1 AR 045000A1
- Authority
- AR
- Argentina
- Prior art keywords
- polynucleotide
- seq
- protein
- sequence described
- polypeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/012—Coccidia antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/455—Eimeria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Proteína de esporocisto oocisto (EtOS22) que pertenece al parásito de la especie Eimeria tenella y polinucleótido que codifica esta proteína, vectores que contienen este polinucleótido, células que se transforman con estos vectores, anticuerpos que son dirigidos contra la proteína, vacunas que comprenden el polinucleótido, la proteína o sus fragmentos, los vectores o anticuerpos mencionados anteriormente dirigidos contra la proteína, y uso del polinucleótido o del polipéptido para hallar los compuestos activos para tratar una infección con Eimeria y compuestos activos que son adecuados para el tratamiento de una infección con Eimeria. Reivindicación 1: Un polinucleótido que comprende: a) la secuencia descripta en la SEC ID NO: 1 o 3; o b) un polinucleótido que exhibe una identidad de más del 50 % con el polinucleótido que tiene la secuencia descripta SEC ID NO: 1 o 3; o c) un polinucleótido que se hibridiza, en condiciones de rigurosidad, con el polinucleótido que tiene la secuencia descripta en la SEC ID NO: 1 o 3; o d) un polinucleótido que codifica un polipéptido que tiene la secuencia descripta en la SEC ID NO: 2; o e) un polinucleótido que exhibe una identidad de más del 50 % con un polinucleótido que codifica el polipéptido que tiene la secuencia descripta en la SEC ID NO: 2; o f) un polinucleótido que se hibridiza, en condiciones de rigurosidad, con un polinucleótido que codifica el polipéptido que tiene la secuencia descripta en la SEC ID NO: 2; o g) un polinucleótido que difiere de un polinucleótido que tiene la secuencia descripta en la SEC ID NO: 1; debido a la degeneración del código genético; h) un polinucleótido que es un fragmento de un polinucleótido según se describe en a) a g) y tiene al menos 6 nucleótidos de largo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10330235A DE10330235A1 (de) | 2003-07-04 | 2003-07-04 | Neues Eimeria Gen und Protein sowie deren Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR045000A1 true AR045000A1 (es) | 2005-10-12 |
Family
ID=33521342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040102341A AR045000A1 (es) | 2003-07-04 | 2004-07-02 | Gen y proteina de eimeria , y su uso |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7691987B2 (es) |
| EP (2) | EP1644407A1 (es) |
| JP (1) | JP4594304B2 (es) |
| AR (1) | AR045000A1 (es) |
| AU (1) | AU2004255594B2 (es) |
| BR (1) | BRPI0412323A (es) |
| CA (1) | CA2531161A1 (es) |
| DE (1) | DE10330235A1 (es) |
| MX (1) | MXPA06000198A (es) |
| NO (1) | NO20060568L (es) |
| NZ (1) | NZ544451A (es) |
| WO (1) | WO2005005472A1 (es) |
| ZA (1) | ZA200510465B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110223208A1 (en) * | 2010-03-09 | 2011-09-15 | Beth Hill | Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
| CN103096934A (zh) * | 2010-03-09 | 2013-05-08 | 詹森生物科技公司 | 非水性高浓度低粘度混悬剂 |
| US9072668B2 (en) | 2010-03-09 | 2015-07-07 | Janssen Biotech, Inc. | Non-aqueous high concentration reduced viscosity suspension formulations of antibodies |
| AU2012338741B2 (en) * | 2011-11-17 | 2015-12-03 | Novonesis Animal Biosolutions Ag | Use of acid stable proteases in animal feed, preferably to increase performance of cocci-vaccinated broiler chickens |
| KR20140121449A (ko) | 2012-01-24 | 2014-10-15 | 유니버시티 오브 매사추세츠 | 췌장 베타-세포 장애에서의 가용성 ｍａｎｆ |
| CN103233017B (zh) * | 2013-05-06 | 2014-11-05 | 扬州大学 | 毒害艾美耳球虫的配子体抗原gam22基因及其应用 |
| US12571802B2 (en) * | 2020-02-29 | 2026-03-10 | President And Fellows Of Harvard College | Nanoswitch caliper trains for high-throughput, high-resolution structural analysis of biomolecules |
| CN111471107B (zh) * | 2020-04-27 | 2023-04-18 | 中国农业大学 | 抗鸡球虫多价重组蛋白卵黄抗体及其制备方法和应用 |
| CN112592961A (zh) * | 2021-01-07 | 2021-04-02 | 山东科硕生物技术有限公司 | 一种核酸样本保存液及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5187080A (en) * | 1984-06-05 | 1993-02-16 | Solvay & Cie S.A. | DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella |
| DE3650540T2 (de) * | 1985-12-03 | 1997-02-27 | Solvay | Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose |
| ZA893740B (en) * | 1988-06-03 | 1990-02-28 | Hoffmann La Roche | Recombinant coccidiosis vaccines |
| JPH06504187A (ja) * | 1990-09-12 | 1994-05-19 | ジェネックス・コーポレーション | 遺伝子操作されたコクシジウム症ワクチン |
-
2003
- 2003-07-04 DE DE10330235A patent/DE10330235A1/de not_active Withdrawn
-
2004
- 2004-06-30 EP EP04740461A patent/EP1644407A1/en not_active Ceased
- 2004-06-30 CA CA002531161A patent/CA2531161A1/en not_active Abandoned
- 2004-06-30 WO PCT/EP2004/007080 patent/WO2005005472A1/en not_active Ceased
- 2004-06-30 AU AU2004255594A patent/AU2004255594B2/en not_active Ceased
- 2004-06-30 EP EP10176984A patent/EP2311859A1/en not_active Withdrawn
- 2004-06-30 BR BRPI0412323-9A patent/BRPI0412323A/pt not_active Application Discontinuation
- 2004-06-30 NZ NZ544451A patent/NZ544451A/en not_active IP Right Cessation
- 2004-06-30 MX MXPA06000198A patent/MXPA06000198A/es active IP Right Grant
- 2004-06-30 US US10/562,324 patent/US7691987B2/en not_active Expired - Fee Related
- 2004-06-30 JP JP2006518068A patent/JP4594304B2/ja not_active Expired - Fee Related
- 2004-07-02 AR ARP040102341A patent/AR045000A1/es unknown
-
2005
- 2005-12-23 ZA ZA200510465A patent/ZA200510465B/xx unknown
-
2006
- 2006-02-03 NO NO20060568A patent/NO20060568L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4594304B2 (ja) | 2010-12-08 |
| EP2311859A1 (en) | 2011-04-20 |
| AU2004255594B2 (en) | 2010-12-09 |
| WO2005005472A1 (en) | 2005-01-20 |
| ZA200510465B (en) | 2007-03-28 |
| EP1644407A1 (en) | 2006-04-12 |
| BRPI0412323A (pt) | 2006-08-22 |
| US7691987B2 (en) | 2010-04-06 |
| CA2531161A1 (en) | 2005-01-20 |
| MXPA06000198A (es) | 2006-03-21 |
| DE10330235A1 (de) | 2005-01-20 |
| NO20060568L (no) | 2006-03-31 |
| JP2008500003A (ja) | 2008-01-10 |
| AU2004255594A1 (en) | 2005-01-20 |
| US20070184054A1 (en) | 2007-08-09 |
| NZ544451A (en) | 2009-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022013121A2 (es) | Vacuna 2019-ncov (sars-cov-2) | |
| ES2525677T3 (es) | Celulasas, genes que las codifican y usos de las mismas | |
| AR047347A1 (es) | Miembros de la familia cry9 de bacillus | |
| DK289688A (da) | Ekspression af proapolipoprotein a-i. | |
| AR096027A2 (es) | Proteínas insecticidas quiméricas de bacillus thuringiensis | |
| ES2668926T3 (es) | Composición de ARN para el tratamiento del cáncer pulmonar de células no pequeñas (NSCLC) | |
| MX353906B (es) | Metodo para la produccion de acidos grasos poli-insaturados en organismos transgenicos. | |
| CO5700788A2 (es) | Composiciones y metodos para inmunoterapia especifica de wt1 | |
| PT1548032E (pt) | Péptidos kdr e vacinas que os contêm | |
| BRPI0412799A (pt) | imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura | |
| PE20200722A1 (es) | Metodos de terapia genica del factor viii (fviii) | |
| BR112022006842A2 (pt) | Construtos de igf2 variante | |
| AR085167A1 (es) | Polipeptidos de porphyromonas gingivalis, metodo de tratamiento, uso, anticuerpo y kit | |
| CY1118861T1 (el) | Αναγνωριση εξω-κυτταρικης μορφης του ρτεν που μπορει να χρησιμοποιηθει για την θεραπεια ογκων | |
| AR045000A1 (es) | Gen y proteina de eimeria , y su uso | |
| AR039460A1 (es) | Factores camp quimericos | |
| PE20220429A1 (es) | Vectores viricos que codifican variantes del fviii recombinantes con mayor expresion para la genoterapia de la hemofilia a | |
| PE20240915A1 (es) | Composiciones y metodos para tratar la enfermedad de fabry | |
| CL2020002373A1 (es) | Composición de vacuna que comprende un péptido aislado de piojo de mar; uso de la vacuna para para prevenir o controlar una infestación de piojos de mar en un salmónido; vector; célula hospedadora (divisional de la solicitud no. 201900422). | |
| PE20230487A1 (es) | Variantes de alfa-galactosidasa humana | |
| CL2009001249A1 (es) | Uso de una enzima pectonilitica endopoligalacturonasa para tratar pure de frutas o verduras; procedimiento para tratamiento enzimatico; molecula de adn que codifica un polipeptido con actividad endopoligalacturonasa; polipeptido, vector de expresion y celula huesped que comprende dicha secuencia. | |
| RU2339692C2 (ru) | Туберкулезные вакцины, содержащие рекомбинантные штаммы бцж, экспрессирующие аланиндегидрогеназу, сериндегидратазу и/или глютаминсинтетазу | |
| AR040521A1 (es) | Gen sisntetico que codifica al factor estimulante de colonias de granulocitos humano para la expresion e. coli | |
| AR051853A1 (es) | Vacuna para aumentar el crecimiento basada en epitopes neutralizantes | |
| MX2024005281A (es) | Celula de levadura recombinante. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |